Respiratory Meets: Hepatology

Respiratory Meets: Hepatology

To take part in this event, you must register in advance.

You are registered to this event

 

16 December, 2025 | Online

18:00-19:00 CET

Respiratory Meets: Hepatology will focus on a topic on which respiratory and liver care intersect - alpha-1 antitrypsin deficiency (AATD).

 

Respiratory and hepatology experts will cover:

  • The diagnosis, genotyping, and phenotyping of AATD;
  • Assessment and management of lung disease (emphysema, bronchiectasis);
  • Evaluation and monitoring of liver disease;
  • The benefits of joint respiratory-hepatology clinics;
  • Family screening, lifestyle advice, and ongoing research

Plus much more. Audience members can ask questions at any point during the live broadcast.

 

Attendance at this event is free, but registration in advance is required.

 


Topics:

  • Epidemiology
  • Early lung disease
  • Chronic liver disease or abnormal liver biochemistry
  • Paediatric transition
  • Family screening
  • Randoms screening
  • Alpha-1 deficiency (AATD)
  • Natural history
  • Basal emphysema
  • Bronchiectasis
  • COPD
  • Non-invasive fibrosis assessment

Target audience:

  • Airway diseases specialists
  • Respiratory professionals with an interest in AATD, COPD and bronchiectasis
  • Respiratory infections specialists

 

Panel:

Chair: Dr Sheila Ramjug

Consultant pulmonologist with a specialist interest in interstitial lung disease and pulmonary vascular disease working at?Salford Hospital Foundation Trust, Manchester, United Kingdom.

Speaker: Prof. John Hurst

Professor of Respiratory Medicine at University College London, United Kingdom, and an Honorary Consultant Respiratory Physician at the Royal Free Hospital in London.? John has a particular interest in COPD exacerbations, clinical trials and cardiovascular risk in COPD.

Speaker: Dr Aileen Marshall

Consultant Hepatologist and Honorary Senior Lecturer at the Royal Free Hospital and UCL Institute of Liver and Digestive Health. Her key areas of interest are liver transplant medicine, hepatocellular carcinoma, autoimmune liver disease, and palliative care for patients with advanced liver disease. Aileen is also the services lead for Hepatology for the Royal Free NHS Foundation Trust.